Baker S, Krishna A, Higham S, Naydenova P, OLeary S, Scott J
Nat Commun. 2024; 15(1):7979.
PMID: 39266557
PMC: 11392949.
DOI: 10.1038/s41467-024-52357-8.
Yamada N, Kamoshida G, Shiraishi T, Yamaguchi D, Matsuoka M, Yamauchi R
J Bacteriol. 2024; 206(5):e0043523.
PMID: 38661375
PMC: 11112996.
DOI: 10.1128/jb.00435-23.
Hassannia M, Naderifar M, Salamy S, Akbarizadeh M, Mohebi S, Moghadam M
Bioprocess Biosyst Eng. 2023; 47(3):301-312.
PMID: 37962644
DOI: 10.1007/s00449-023-02938-6.
Thabit A, Alabbasi A, Alnezary F, Almasoudi I
Microorganisms. 2023; 11(8).
PMID: 37630646
PMC: 10460018.
DOI: 10.3390/microorganisms11082086.
Mousavi S, Babakhani S, Moradi L, Karami S, Shahbandeh M, Mirshekar M
Curr Microbiol. 2021; 78(12):4023-4036.
PMID: 34633487
PMC: 8503728.
DOI: 10.1007/s00284-021-02662-y.
Antibiotics Profile, Prevalence of Extended-Spectrum Beta-Lactamase (ESBL), and Multidrug-Resistant from Different Clinical Samples in Khartoum State, Sudan.
Moglad E
Int J Microbiol. 2020; 2020:8898430.
PMID: 33163078
PMC: 7605932.
DOI: 10.1155/2020/8898430.
Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran.
Mirzaei B, Bazgir Z, Goli H, Iranpour F, Mohammadi F, Babaei R
BMC Res Notes. 2020; 13(1):380.
PMID: 32778154
PMC: 7418330.
DOI: 10.1186/s13104-020-05224-w.
Antibiotic Susceptibility, Clonality, and Molecular Characterization of Carbapenem-Resistant Clinical Isolates of from Washington DC.
Bansal G, Allen-McFarlane R, Eribo B
Int J Microbiol. 2020; 2020:2120159.
PMID: 32695174
PMC: 7368205.
DOI: 10.1155/2020/2120159.
Monoclonal IgM Antibodies Targeting Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria.
Youssef E, Zhang L, Alkhazraji S, Gebremariam T, Singh S, Yount N
Front Immunol. 2020; 11:76.
PMID: 32153560
PMC: 7045048.
DOI: 10.3389/fimmu.2020.00076.
-Cinnamaldehyde and Eugenol Increase Sensitivity to Beta-Lactam Antibiotics.
Karumathil D, Surendran Nair M, Gaffney J, Kollanoor-Johny A, Venkitanarayanan K
Front Microbiol. 2018; 9:1011.
PMID: 29875743
PMC: 5974060.
DOI: 10.3389/fmicb.2018.01011.
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef E, Alkhazraji S
PLoS Pathog. 2018; 14(5):e1007056.
PMID: 29746596
PMC: 5963808.
DOI: 10.1371/journal.ppat.1007056.
A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii.
Chin C, Tipton K, Farokhyfar M, Burd E, Weiss D, Rather P
Nat Microbiol. 2018; 3(5):563-569.
PMID: 29693659
PMC: 5921939.
DOI: 10.1038/s41564-018-0151-5.
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
Nielsen T, Pantapalangkoor P, Luna B, Bruhn K, Yan J, Dekitani K
J Infect Dis. 2017; 216(4):489-501.
PMID: 28931235
PMC: 5853763.
DOI: 10.1093/infdis/jix315.
Essential Oils and Their Components as Modulators of Antibiotic Activity against Gram-Negative Bacteria.
Aelenei P, Miron A, Trifan A, Bujor A, Gille E, Aprotosoaie A
Medicines (Basel). 2017; 3(3).
PMID: 28930130
PMC: 5456245.
DOI: 10.3390/medicines3030019.
Failure to Communicate: Transmission of Extensively Drug-Resistant bla OXA-237-Containing Acinetobacter baumannii-Multiple Facilities in Oregon, 2012-2014.
Buser G, Maureen Cassidy P, Cunningham M, Rudin S, Hujer A, Vega R
Infect Control Hosp Epidemiol. 2017; 38(11):1335-1341.
PMID: 28870269
PMC: 5783543.
DOI: 10.1017/ice.2017.189.
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
Li Y, Pan C, Fang C, Zhao Z, Chen H, Guo P
BMC Infect Dis. 2017; 17(1):371.
PMID: 28558660
PMC: 5450129.
DOI: 10.1186/s12879-017-2471-0.
Molecular Epidemiology of Multi-Drug Resistant Isolated in Shandong, China.
Jiang M, Liu L, Ma Y, Zhang Z, Li N, Zhang F
Front Microbiol. 2016; 7:1687.
PMID: 27818659
PMC: 5073130.
DOI: 10.3389/fmicb.2016.01687.
The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity.
June C, Muckenthaler T, Schroder E, Klamer Z, Wawrzak Z, Powers R
Protein Sci. 2016; 25(12):2152-2163.
PMID: 27636561
PMC: 5119573.
DOI: 10.1002/pro.3040.
Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems.
Schroder E, Klamer Z, Saral A, Sugg K, June C, Wymore T
Antimicrob Agents Chemother. 2016; 60(10):6155-64.
PMID: 27480863
PMC: 5038279.
DOI: 10.1128/AAC.01277-16.
Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment.
Wright M, Iovleva A, Jacobs M, Bonomo R, Adams M
Genome Med. 2016; 8(1):26.
PMID: 26939581
PMC: 4776386.
DOI: 10.1186/s13073-016-0279-y.
